Interclean Shanghai

BWH has added the IMRISNV and IMRIScardio to the advanced multimodality image guided operating (AMIG

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Brigham and Women’s Hospital has added the IMRISNV and IMRIScardio to the Advanced Multimodality Image Guided Operating (AMIGO) suite, combining the most advanced and complete image guidance capabilities in a single suite with the goal of delivering the best possible therapy to patients across a range of applications including neurological, neurovascular, oncological and cardiovascular disorders.

BWH has added the IMRISNV and IMRIScardio to the advanced multimodality image guided operating (AMIGO) suite

Brigham and Women’s Hospital has added the IMRISNV and IMRIScardio to the Advanced Multimodality Image Guided Operating (AMIGO) suite, combining the most advanced and complete image guidance capabilities in a single suite with the goal of delivering the best possible therapy to patients across a range of applications including neurological, neurovascular, oncological and cardiovascular disorders.

The IMRIS system is the first in the world to allow the capabilities of both MRI and x-ray angiography in a single suite eliminating the need to transport the patient between modalities. In addition, no other system offers the same degree of safety for both the patient and the surgical environment. Ferenc Jolesz, MD, director of the Division of MRI and Image Guided Therapy Program at BWH, believes IMRIS’s capabilities best meet the hospital’s requirements for achieving the vision of AMIGO.

IMRISNV and IMRIScardio, which were recently cleared by the FDA, include an MR diagnostic center and interventional theatre, incorporating a Siemens wide bore 3T MRI and single plane angiography system. The system will permit rapid and seamless transitions between MR imaging and intervention without transporting the patient between modalities. MR images can be taken before and during procedures to assess tissue health, and can also be used in conjunction with the fluoroscopic images during interventional procedures.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »